Related Experiment Video
Updated: Apr 11, 2026

Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
Development of human monoclonal antibodies against TARM1 by yeast display
Rikio Yabe1, Mayumi Saeki1, Masaaki Hashiguchi1
1Cancer Immunology Project, Tokyo Metropolitan Institute of Medical Science, Setagaya, Japan.
Abstract:
TARM1, a leukocyte immunoglobulin-like receptor expressed on myeloid cells, functions as a costimulatory receptor promoting proinflammatory cytokine secretion. Recent studies have revealed the involvement of TARM1 in immune-mediated diseases. Despite its biological importance, research tools for elucidating human TARM1 function have been limited. Here, we generated monoclonal antibodies (mAbs) against human TARM1 by a yeast display platform combined with a human single-chain variable fragment (scFv) library. Two scFv clones were isolated and converted into IgG1 antibodies, both of which bound recombinant TARM1 with high affinity and cell-surface TARM1. Importantly, these antibodies induced activation signals into Jurkat NFAT-GFP reporter cells expressing TARM1-CD28-4-1BB-CD3ζ chimera, indicating agonistic activity. These mAbs provide valuable tools for dissecting TARM1-mediated function and represent a potential approach for therapeutic strategies in inflammatory diseases and cancer.

